ME Therapeutics investor Dhanji acquires shares

Executive Summary

• Rahim Dhanji, via his controlled entity 1307622 B.C. Ltd., increased his ownership in ME Therapeutics Holdings Inc. to 13.02% of outstanding shares through a combination of warrant exercises and market purchases.
• The acquiror exercised 1.6 million common share purchase warrants at $0.25 per warrant, acquiring 1.6 million new shares for $400,000.
• Following the warrant exercise, the acquiror purchased an additional 3,875 shares on the Canadian Securities Exchange at an average price of $9.06 per share.

Key Details

• Warrant Exercise:
  • Date: January 26, 2025
  • Quantity of Warrants Exercised: 1,600,000
  • Exercise Price: $0.25 per warrant
  • Shares Acquired via Exercise: 1,600,000 common shares
  • Total Cost of Exercise: $400,000
• Market Purchases:
  • Quantity of Shares Purchased: 3,875
  • Average Market Price: $9.06 per share
  • Exchange: Canadian Securities Exchange
• Ownership Position:
  • Pre-Exercise Holdings: 2,248,115 common shares (8.58% of outstanding)
  • Post-Exercise Holdings (before market purchases): 3,848,115 common shares (13.01% of outstanding)
  • Final Holdings (as of report date): 3,851,990 common shares (13.02% of outstanding)
• Purpose: Shares were acquired for investment purposes; future acquisitions or dispositions are subject to market conditions and other opportunities.
• Regulatory Context: Report filed under National Instrument 62-103 and National Instrument 62-104.